PTX.AX · PRESCIENT THERAPEUTICS LIMITED
Australia · RS rating 64 · As of 2026-10-14
| Price | 0.06 AUD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 64 / 58 / 36 / 90 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 38 / 36 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +38.1% |
| Market cap (USD) | $52.5M |